Dysregulation of TGFβ signaling, another mechanism associated with chemoresistance, is implicated in the progression of various cancers, including lung [43], prostate [44], colon [45], breast and pancreatic cancer [46]. This evidence concerns the gene TGFB1 and familial pancreatic carcinoma.